The Patent Finder

Cytune Pharma

7 patents currently held · Updated Nov 22, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 12, 2027
    The maintenance fee for IL-15 and IL-15R\ALPHA Sushi Domain Based Immunocytokines (US 11,753,454) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
  • 1 fee due Oct 21, 2027
    The maintenance fee for IL-15 AND IL-15R\alpha SUSHI DOMAIN BASED IMMUNOCYTOKINES (US 10,626,155) comes due Oct 21, 2027. Unpaid by Apr 21, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,899,816IL-15 and IL-15R\ALPHA Sushi Domain Based Immunocytokines
In force
 · Low confidence
In forceLow confidence
US 10,626,155IL-15 AND IL-15R\alpha SUSHI DOMAIN BASED IMMUNOCYTOKINES
In force
 · Medium confidence
In forceMedium confidence
US 11,753,454IL-15 and IL-15R\ALPHA Sushi Domain Based Immunocytokines
In force
 · Medium confidence
In forceMedium confidence
US 11,401,312Cytokine derived treatment with reduced vascular leak syndrome
In force
 · USPTO record
In forceUSPTO record
US 10,808,022IL-15/IL-15RALPHA Based Conjugates Purification Method
In force
 · High confidence
In forceHigh confidence
US 12,060,407IL-15/IL-15RALPHA Based Conjugates Purification Method
In force
 · High confidence
In forceHigh confidence
US 12,661,387IL-2/IL-15R Beta Gamma Agonist Dosing Regimens for Treating Cancer or Infectious Diseases
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 1 abandoned · 3 no status recorded

Showing 1 to 10 of 10, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/352,998IL-15 and IL-15R\ALPHA Sushi Domain Based ImmunocytokinesJul 14, 2023Pending
18/683,180IL-2/IL-15RBETAGAMMA Agonist Combination with Antibody-Drug Conjugates for Treating CancerAug 16, 2022Pending
17/876,987Jul 29, 2022No status recorded
18/573,397INTERLEUKIN-15 Based ImmunocytokinesJun 23, 2022Pending
17/695,688Combined Pharmaceutical CompositionMar 15, 2022Pending
17/693,132IL-15 and IL-15RALPHA Sushi Domain Based ModulokinesMar 11, 2022Pending
17/677,589Feb 22, 2022No status recorded
18/033,773IL-2/IL-15R-BETA-GAMMA Agonist for Treating Squamous Cell CarcinomaOct 26, 2021Pending
18/033,524Oct 26, 2021No status recorded
14/910,491Combined Pharmaceutical CompositionAug 8, 2014Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited